If eligible, the provider prescribes an FDA-approved GLP-1
Serious risks are rare but possible, including inflammation of the pancreas, gallbladder issues, or changes in mood
Water retention, particularly in the first two weeks, is the most common
Seek medical help for severe abdominal pain, persistent vomiting, signs of dehydration, allergic reactions, vision changes, or symptoms of low blood sugar (Hypoglycemia)
[1] Key Facts About Oral Wegovy Same active ingredient as injectable Wegovy (semaglutide) No injections required daily pill instead of weekly injection Comparable weight loss 16.6% in clinical trials (vs 14.9% injectable) Also approved for CV risk reduction same cardiovascular benefits No refrigeration needed store at room temperature Launches January 2026 ask your doctor now to plan ahead Why This Matters For the first time, you can get prescription GLP-1 weight loss medication without injections
A 5 mg/mL vial at 10 units gives 0.5 mg